Inovio Pharmaceuticals Inc. Stock Rallies 3.5%, Outperforms Market

Dow Jones
Oct 10

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. advanced 3.5% to $2.65 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 23,024.63 and Dow Jones Industrial Average falling 0.5% to 46,358.42.

This was the stock's second consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 54.5% below its 52-week high of $5.83, which the company reached on October 21st.

The stock demonstrated a mixed performance when compared to some of its peers, as Johnson & Johnson rose 0.7% to $191.08, Statera Biopharma Inc. rose 100.0% to $0.00, and Pfizer Inc. fell 1.71% to $25.24.

Trading volume totaled 917,444, compared to the 50-day average of 1.7 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 09, 2025 16:35 ET (20:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10